carbamazepine has been researched along with Peripheral Nerve Diseases in 46 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Increasing evidence suggests that oxcarbazepine can provide significant analgesia in several neuropathic pain conditions, including trigeminal neuralgia and PDN, and is also may be effective in treating neuropathic pain refractory to other AEDs, such as carbamazepine and gabapentin." | 8.82 | Rationale and evidence for the use of oxcarbazepine in neuropathic pain. ( Carrazana, E; Mikoshiba, I, 2003) |
| " Based on the experience with carbamazepine, gabapentin, and lamotrigine, these newer AEDs are being investigated for the management of neuropathic pain." | 8.82 | Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain. ( Guay, DR, 2003) |
| "The results of 7 open-label clinical studies on oxcarbazepine (OXC) in different neuropathic pain conditions, sharing the same protocols, were pooled together in order to evaluate whether the results obtained in the individual trials were confirmed in the pooled analysis of this larger sample, providing more evidence for efficacy and tolerability of OXC in these conditions." | 7.73 | Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies. ( Arghetti, S; Bianconi, C; Cavallotti, G; Di Palma, F; Galimberti, V; Jann, S; Magenta, P; Osio, M; Siciliano, G; Sterlicchio, M; Sterzi, R, 2005) |
| "Neuropathic pain is the most severe and resistant type of pain which has impact on quality of life and behaviour; it most commonly occurs at night causing disturbed sleep." | 6.84 | Comparative role of pregabalin and carbamazepine regarding efficacy in painful diabetic neuropathy. ( Jawed, I; Kamil, A; Khan, MI; Mahmood, I; Mahmood, R; Sayeed, BZ; Sayeed, FZ; Tariq, T, 2017) |
| " Notably, we demonstrated the positive effects of carbamazepine in treating muscle stiffness and cramps of ARAN-NM." | 5.22 | A novel mutation in HINT1 gene causes autosomal recessive axonal neuropathy with neuromyotonia, effective treatment with carbamazepine and review of the literature. ( Lin, P; Lv, X; Wang, G; Xu, L; Yan, C; Zhang, D, 2022) |
| " Multiple multicentre randomised controlled trials have shown clear efficacy of gabapentin and pregabalin for postherpetic neuralgia and painful diabetic neuropathy." | 4.84 | Antiepileptic drugs in the treatment of neuropathic pain. ( Eisenberg, E; Krivoy, N; River, Y; Shifrin, A, 2007) |
| " Increasing evidence suggests that oxcarbazepine can provide significant analgesia in several neuropathic pain conditions, including trigeminal neuralgia and PDN, and is also may be effective in treating neuropathic pain refractory to other AEDs, such as carbamazepine and gabapentin." | 4.82 | Rationale and evidence for the use of oxcarbazepine in neuropathic pain. ( Carrazana, E; Mikoshiba, I, 2003) |
| " Based on the experience with carbamazepine, gabapentin, and lamotrigine, these newer AEDs are being investigated for the management of neuropathic pain." | 4.82 | Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain. ( Guay, DR, 2003) |
| " Reversible dystonia may occasionally be precipitated by phenytoin or carbamazepine; asterixis by phenytoin, barbiturates or carbamazepine; and, more commonly, tremor by valproate." | 4.77 | Adverse neuropsychiatric effects of anticonvulsant drugs. ( Reynolds, EH; Trimble, MR, 1985) |
| "Muscle cramps associated with PNH respond well to symptomatic treatment, particularly with carbamazepine and gabapentin." | 3.83 | Therapeutic Implications of Peripheral Nerve Hyperexcitability in Muscle Cramping: A Retrospective Review. ( Hobson-Webb, LD; Hurst, RL, 2016) |
| "Young adult outpatients with epilepsy on monotherapy for no less than 6 months with carbamazepine (CBZ), valproic acid (VPA), oxcarbazepine (OXC) and topiramate (TPM) were examined." | 3.76 | Effects of the antiepileptic drugs on peripheral nerve function. ( Boylu, E; Domaç, FM; Misirli, H; Saraçoğlu, M; Senol, MG, 2010) |
| "The results of 7 open-label clinical studies on oxcarbazepine (OXC) in different neuropathic pain conditions, sharing the same protocols, were pooled together in order to evaluate whether the results obtained in the individual trials were confirmed in the pooled analysis of this larger sample, providing more evidence for efficacy and tolerability of OXC in these conditions." | 3.73 | Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies. ( Arghetti, S; Bianconi, C; Cavallotti, G; Di Palma, F; Galimberti, V; Jann, S; Magenta, P; Osio, M; Siciliano, G; Sterlicchio, M; Sterzi, R, 2005) |
| "Neuropathic pain is the most severe and resistant type of pain which has impact on quality of life and behaviour; it most commonly occurs at night causing disturbed sleep." | 2.84 | Comparative role of pregabalin and carbamazepine regarding efficacy in painful diabetic neuropathy. ( Jawed, I; Kamil, A; Khan, MI; Mahmood, I; Mahmood, R; Sayeed, BZ; Sayeed, FZ; Tariq, T, 2017) |
| "Classically, trigeminal neuralgia has been described as a paroxysmal, lancinating, knifelike pain which is limited to the anatomic pathways of the fifth cranial nerve." | 2.36 | Trigeminal neuralgia: an overview. ( Bayer, DB; Stenger, TG, 1979) |
| "Fabry's disease is an X-linked multisistemic lisosomal storage disorder caused by deficiency or absence in α-Galatosidase A." | 1.48 | [Neuropathy and Fabry's disease. Report of five cases]. ( Jara, P; Matamala, JM; Verdugo, R, 2018) |
| "Significant allodynia and hyperalgesia to cold stimuli were rapidly observed from 24 h to day 5 with a maximum lowering of 76% at t+30 h versus control." | 1.34 | Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat. ( Authier, N; Balayssac, D; Coudoré, F; Coudoré-Civiale, MA; Eschalier, A; Ling, B, 2007) |
| " Hill slope coefficients for the tested anticonvulsants indicate that the dose-response curve was less steep for gabapentin than for phenytoin, carbamazepine and ethosuximide." | 1.32 | Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. ( Jevtovic-Todorovic, V; Rastogi, AJ; Todorovic, SM, 2003) |
| "Carbamazepine levels were 4." | 1.31 | [Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study]. ( Adelsberger, H; Eckel, F; Erdmann, J; Lersch, C; Quasthoff, S; Schmelz, R, 2002) |
| "Carbamazepine therapy was tried in 12 additional patients to determine whether the neurologic effects might be relieved." | 1.31 | Acute oxaliplatin-induced peripheral nerve hyperexcitability. ( Floeter, MK; Grem, JL; Lehky, T; Quinn, MG; Thomas, RR; Wilson, RH, 2002) |
| "Morphine pre-treatment was less effective in preventing development of hyperalgesia; however, whilst the ipsilateral (146 +/- 18 g) paw withdrawal threshold tended to be lower than the contralateral (183 +/- 8 g), this was not significant." | 1.29 | Pre-emptive administration of clonidine prevents development of hyperalgesia to mechanical stimuli in a model of mononeuropathy in the rat. ( Birch, PJ; Elliott, PJ; Harrison, SM; Smith, GD; Wiseman, J, 1993) |
| "Neuromyotonia is a rare condition of peripheral nerve dysfunction characterized by the signs of motor nerve hyperactivity, namely, myokymia, fasciculations, and muscular stiffness." | 1.28 | Neuromyotonia: report of a case. ( Feldmann, M; Kukowski, B, 1992) |
| "Neurologic examination showed calf fasciculations in seven, quadriceps myokymia in two, and deltoid myokymia in one patient." | 1.28 | Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder. ( Alonso, RJ; Heiman-Patterson, TD; Tahmoush, AJ; Tahmoush, GP, 1991) |
| " We found a noticeable relationship between conduction velocity slowing and daily dosage for CBZ only." | 1.27 | Anticonvulsant therapy and its possible consequences on peripheral nervous system: a neurographic study. ( Faedda, MT; Geraldini, C; Sideri, G, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (32.61) | 18.7374 |
| 1990's | 6 (13.04) | 18.2507 |
| 2000's | 16 (34.78) | 29.6817 |
| 2010's | 8 (17.39) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, J | 1 |
| Gharagozloo, P | 1 |
| Yao, J | 1 |
| Ilyin, VI | 2 |
| Carter, RB | 2 |
| Nguyen, P | 2 |
| Robledo, S | 2 |
| Woodward, RM | 1 |
| Hogenkamp, DJ | 1 |
| Shao, B | 1 |
| Victory, S | 1 |
| Goehring, RR | 1 |
| Sun, Q | 1 |
| Hogenkamp, D | 1 |
| Hodges, DD | 1 |
| Islam, K | 1 |
| Sha, D | 1 |
| Zhang, C | 1 |
| Sakellaropoulos, G | 1 |
| Yogeeswari, P | 1 |
| Ragavendran, JV | 1 |
| Sriram, D | 1 |
| Nageswari, Y | 1 |
| Kavya, R | 1 |
| Sreevatsan, N | 1 |
| Vanitha, K | 1 |
| Stables, J | 1 |
| Xu, L | 1 |
| Wang, G | 1 |
| Lv, X | 1 |
| Zhang, D | 1 |
| Yan, C | 1 |
| Lin, P | 1 |
| Mahmood, R | 1 |
| Jawed, I | 1 |
| Khan, MI | 1 |
| Mahmood, I | 1 |
| Tariq, T | 1 |
| Kamil, A | 1 |
| Sayeed, FZ | 1 |
| Sayeed, BZ | 1 |
| Jara, P | 1 |
| Matamala, JM | 1 |
| Verdugo, R | 1 |
| Demant, DT | 1 |
| Lund, K | 1 |
| Vollert, J | 1 |
| Maier, C | 1 |
| Segerdahl, M | 1 |
| Finnerup, NB | 1 |
| Jensen, TS | 1 |
| Sindrup, SH | 1 |
| Baron, R | 1 |
| Dickenson, AH | 1 |
| Chu, SH | 1 |
| Lee, YJ | 1 |
| Lee, ES | 1 |
| Geng, Y | 1 |
| Wang, XS | 1 |
| Cleeland, CS | 1 |
| Hurst, RL | 1 |
| Hobson-Webb, LD | 1 |
| Boylu, E | 1 |
| Domaç, FM | 1 |
| Misirli, H | 1 |
| Senol, MG | 1 |
| Saraçoğlu, M | 1 |
| Kitada, M | 1 |
| Suzuki, H | 1 |
| Ichihashi, J | 1 |
| Inada, R | 1 |
| Miyamoto, K | 1 |
| Takahashi, T | 1 |
| Mitsui, Y | 1 |
| Fujihara, K | 1 |
| Kusunoki, S | 1 |
| Lersch, C | 2 |
| Schmelz, R | 2 |
| Eckel, F | 2 |
| Erdmann, J | 2 |
| Mayr, M | 1 |
| Schulte-Frohlinde, E | 1 |
| Quasthoff, S | 2 |
| Grosskreutz, J | 1 |
| Adelsberger, H | 2 |
| Walker, KM | 1 |
| Urban, L | 1 |
| Medhurst, SJ | 1 |
| Patel, S | 1 |
| Panesar, M | 1 |
| Fox, AJ | 1 |
| McIntyre, P | 1 |
| Carrazana, E | 1 |
| Mikoshiba, I | 1 |
| Ardid, D | 1 |
| Lamberty, Y | 1 |
| Alloui, A | 1 |
| Coudore-Civiale, MA | 2 |
| Klitgaard, H | 1 |
| Eschalier, A | 2 |
| Todorovic, SM | 1 |
| Rastogi, AJ | 1 |
| Jevtovic-Todorovic, V | 1 |
| Guay, DR | 1 |
| Ben Ghorbel, I | 1 |
| Ibnelhadj, Z | 1 |
| Zouari, M | 1 |
| Nagi, S | 1 |
| Khanfir, M | 1 |
| Hentati, F | 1 |
| Houman, MH | 1 |
| Magenta, P | 1 |
| Arghetti, S | 1 |
| Di Palma, F | 1 |
| Jann, S | 1 |
| Sterlicchio, M | 1 |
| Bianconi, C | 1 |
| Galimberti, V | 1 |
| Osio, M | 1 |
| Siciliano, G | 1 |
| Cavallotti, G | 1 |
| Sterzi, R | 1 |
| Ling, B | 1 |
| Balayssac, D | 1 |
| Coudoré, F | 1 |
| Authier, N | 1 |
| Eisenberg, E | 1 |
| River, Y | 1 |
| Shifrin, A | 1 |
| Krivoy, N | 1 |
| Geraldini, C | 1 |
| Faedda, MT | 1 |
| Sideri, G | 1 |
| Shorvon, SD | 1 |
| Reynolds, EH | 2 |
| Moglia, A | 1 |
| Arrigo, A | 1 |
| Zandrini, C | 1 |
| Scelsi, R | 1 |
| Mutani, R | 1 |
| Monaco, F | 1 |
| Fassio, F | 1 |
| Traccis, S | 1 |
| Smith, GD | 1 |
| Harrison, SM | 1 |
| Wiseman, J | 1 |
| Elliott, PJ | 1 |
| Birch, PJ | 1 |
| Savk, E | 1 |
| Bolukbasi, O | 1 |
| Akyol, A | 1 |
| Karaman, G | 1 |
| Wilson, RH | 1 |
| Lehky, T | 1 |
| Thomas, RR | 1 |
| Quinn, MG | 1 |
| Floeter, MK | 1 |
| Grem, JL | 1 |
| Zarday, Z | 1 |
| Soberman, RJ | 1 |
| Harik, SI | 1 |
| Baraka, AS | 1 |
| Tomeh, GF | 1 |
| Mire-Salman, J | 1 |
| Kronful, Z | 1 |
| Afifi, AK | 1 |
| Bada, JL | 1 |
| Cervera, C | 1 |
| Padro, L | 1 |
| Lai, CW | 1 |
| Hung, TP | 1 |
| Lin, WS | 1 |
| Bayer, DB | 1 |
| Stenger, TG | 1 |
| Baldini, S | 1 |
| Carenini, L | 1 |
| Leone, M | 1 |
| D'Alessandro, G | 1 |
| Bottacchi, E | 1 |
| Kukowski, B | 1 |
| Feldmann, M | 1 |
| Tahmoush, AJ | 1 |
| Alonso, RJ | 1 |
| Tahmoush, GP | 1 |
| Heiman-Patterson, TD | 1 |
| Skelton, WP | 2 |
| Skelton, NK | 1 |
| Hahn, AF | 1 |
| Parkes, AW | 1 |
| Bolton, CF | 1 |
| Stewart, SA | 1 |
| Malapert, D | 1 |
| Degos, JD | 1 |
| Hartung, HP | 1 |
| Heininger, K | 1 |
| Toyka, KV | 1 |
| Trimble, MR | 1 |
| Halonen, P | 1 |
| Lang, HA | 1 |
| Nyrke, T | 1 |
| Cambier, J | 1 |
| Dehen, H | 1 |
| Eisen, AA | 1 |
| Woods, JF | 1 |
| Sherwin, AL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Placebo-Controlled Crossover Trial of Levetiracetam on Ethanol Intake[NCT01168687] | 46 participants (Actual) | Interventional | 2008-11-30 | Completed | |||
| Pilot Study of Oxaliplatin in Combination With Capecitabine in Adult Cancer Patients[NCT00019773] | Phase 1 | 0 participants | Interventional | 1999-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary outcome of this study is to determine the effect of levetiracetam on alcohol consumption as measured by change in # of drinks during each treatment period. (NCT01168687)
Timeframe: During each 14 day treatment period
| Intervention | number of drinks per treatment period (Mean) |
|---|---|
| All Subjects (n = 46) Placebo | 41.2 |
| All Subjects (n = 46) Levetiracetam | 45.4 |
9 reviews available for carbamazepine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
A novel mutation in HINT1 gene causes autosomal recessive axonal neuropathy with neuromyotonia, effective treatment with carbamazepine and review of the literature.
Topics: Adolescent; Carbamazepine; Charcot-Marie-Tooth Disease; Histidine; Humans; Isaacs Syndrome; Muscle C | 2022 |
Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Antineoplastic Agents; Boronic Acids; Bortezo | 2015 |
Rationale and evidence for the use of oxcarbazepine in neuropathic pain.
Topics: Anticonvulsants; Carbamazepine; Central Nervous System Diseases; Clinical Trials as Topic; Diabetic | 2003 |
Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain.
Topics: Aged; Analgesics, Non-Narcotic; Animals; Carbamazepine; Clinical Trials as Topic; Dose-Response Rela | 2003 |
Antiepileptic drugs in the treatment of neuropathic pain.
Topics: Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Fructose; Gabapentin; gamma-Ami | 2007 |
Trigeminal neuralgia: an overview.
Topics: Age Factors; Aged; Anesthetics, Local; Carbamazepine; Diagnosis, Differential; Electrocoagulation; F | 1979 |
[Painful legs and moving toes. Neuropathy caused by cytarabine].
Topics: Adolescent; Axons; Carbamazepine; Cytarabine; Dose-Response Relationship, Drug; Humans; Leg; Male; M | 1989 |
[Neuromuscular manifestations of HIV-1 and HTLV-I infections].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adrenal Cortex Hormones; Capsaicin; Carbamazepine; De | 1988 |
Adverse neuropsychiatric effects of anticonvulsant drugs.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Barbiturates; Benzodiazepines; Biogenic Amines; Carba | 1985 |
3 trials available for carbamazepine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Comparative role of pregabalin and carbamazepine regarding efficacy in painful diabetic neuropathy.
Topics: Analgesics, Non-Narcotic; Carbamazepine; Diabetic Neuropathies; Female; Humans; Male; Medical Record | 2017 |
The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study.
Topics: Adult; Aged; Aged, 80 and over; Carbamazepine; Cross-Over Studies; Double-Blind Method; Female; Huma | 2014 |
Neuroleptics in painful thiamine deficiency neuropathy.
Topics: Aged; Carbamazepine; Electromyography; Humans; Male; Middle Aged; Neural Conduction; Pain; Periphera | 1991 |
34 other studies available for carbamazepine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers.
Topics: Analgesics; Animals; Cell Line; Humans; Male; Pain; Patch-Clamp Techniques; Peripheral Nervous Syste | 2004 |
Phenoxyphenyl pyridines as novel state-dependent, high-potency sodium channel inhibitors.
Topics: Analgesics; Animals; Animals, Newborn; Brain; Cell Line; Humans; In Vitro Techniques; Male; NAV1.2 V | 2004 |
Discovery of 4-aminobutyric acid derivatives possessing anticonvulsant and antinociceptive activities: a hybrid pharmacophore approach.
Topics: Analgesics; Animals; Anticonvulsants; Disease Models, Animal; gamma-Aminobutyric Acid; Hyperalgesia; | 2007 |
[Neuropathy and Fabry's disease. Report of five cases].
Topics: Adult; Analgesics, Non-Narcotic; Carbamazepine; Enzyme Replacement Therapy; Fabry Disease; Female; H | 2018 |
Neuropathic pain: precise sensory profiling improves treatment and calls for back-translation.
Topics: Carbamazepine; Female; Humans; Male; Pain; Peripheral Nervous System Diseases; Voltage-Gated Sodium | 2014 |
Therapeutic Implications of Peripheral Nerve Hyperexcitability in Muscle Cramping: A Retrospective Review.
Topics: Amines; Analgesics, Non-Narcotic; Antibodies; Carbamazepine; Cyclohexanecarboxylic Acids; Electric S | 2016 |
Effects of the antiepileptic drugs on peripheral nerve function.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Fructose; Humans; Male; Median Nerve; Neural Condu | 2010 |
Acute combined central and peripheral demyelination showing anti-aquaporin 4 antibody positivity.
Topics: Acute Disease; Antibodies, Anti-Idiotypic; Aquaporin 4; Carbamazepine; Comorbidity; Female; Humans; | 2012 |
Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.
Topics: Animals; Antineoplastic Agents; Carbamazepine; Colorectal Neoplasms; Humans; In Vitro Techniques; Ne | 2002 |
The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.
Topics: Algorithms; Animals; Anticonvulsants; Capsaicin; Carbamazepine; Dose-Response Relationship, Drug; Gu | 2003 |
Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats.
Topics: Acute Disease; Analgesics; Animals; Carbamazepine; Chronic Disease; Constriction, Pathologic; Diabet | 2003 |
Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats.
Topics: Acetates; Amines; Analgesics; Animals; Anticonvulsants; Calcium Channel Blockers; Carbamazepine; Cyc | 2003 |
[Behçet's disease associated with peripheral neuropathy].
Topics: Anti-Inflammatory Agents; Anticonvulsants; Behcet Syndrome; Carbamazepine; Cyclophosphamide; Diarrhe | 2005 |
Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies.
Topics: Adult; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Female; Humans; Male; Oxcarbazepine | 2005 |
Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat.
Topics: Analgesics, Non-Narcotic; Animals; Antineoplastic Agents; Behavior, Animal; Calcitonin Gene-Related | 2007 |
Anticonvulsant therapy and its possible consequences on peripheral nervous system: a neurographic study.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Neural Conduction; Peripheral Nerves; Peripheral N | 1984 |
Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates.
Topics: Adolescent; Adult; Aged; Barbiturates; Carbamazepine; Evoked Potentials, Somatosensory; Humans; Medi | 1982 |
Peripheral nerve function in rats chronically treated with carbamazepine.
Topics: Animals; Carbamazepine; Female; Peripheral Nervous System Diseases; Rats; Rats, Inbred Strains | 1983 |
Pre-emptive administration of clonidine prevents development of hyperalgesia to mechanical stimuli in a model of mononeuropathy in the rat.
Topics: Analysis of Variance; Animals; Baclofen; Carbamazepine; Clonidine; Disease Models, Animal; Hyperalge | 1993 |
Open pilot study on oxcarbazepine for the treatment of notalgia paresthetica.
Topics: Adult; Anticonvulsants; Carbamazepine; Female; Humans; Oxcarbazepine; Peripheral Nervous System Dise | 2001 |
[Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2002 |
Acute oxaliplatin-induced peripheral nerve hyperexcitability.
Topics: Acute Disease; Aged; Anticonvulsants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pr | 2002 |
Letter: Carbamazepine in uremic neuropathy.
Topics: Carbamazepine; Humans; Peripheral Nervous System Diseases; Uremia | 1976 |
Autonomous peripheral nerve activity causing generalized muscle stiffness and fasciculations: report of a case with physiological, pharmacological, and morphological observations.
Topics: Adolescent; Anesthesia, General; Anesthesia, Spinal; Arm; Carbamazepine; Curare; Electromyography; H | 1976 |
Carbamazepine for amyloid neuropathy.
Topics: Amyloidosis; Carbamazepine; Humans; Male; Peripheral Nervous System Diseases | 1977 |
Blindness of cerebral origin in acute intermittent porphyria. Report of a case and postmortem examination.
Topics: Adult; Blindness; Brain; Carbamazepine; Electroencephalography; Epilepsy; Female; Humans; Hypertensi | 1977 |
Peripheral neuropathy caused by antiepileptic drugs. Neurophysiological study of the A delta and C fibers.
Topics: Adolescent; Adult; Aged; Carbamazepine; Cold Temperature; Hot Temperature; Humans; Middle Aged; Nerv | 1992 |
Neuromyotonia: report of a case.
Topics: Adolescent; Carbamazepine; Diagnosis, Differential; Electromyography; Humans; Male; Myotonia; Neurom | 1992 |
Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder.
Topics: Carbamazepine; Electrodiagnosis; Fasciculation; Follow-Up Studies; Humans; Muscle Cramp; Peripheral | 1991 |
Neuromyotonia in hereditary motor neuropathy.
Topics: Adolescent; Anti-Arrhythmia Agents; Carbamazepine; Child; Electromyography; Female; Humans; Lidocain | 1991 |
Neuropathic beriberi and carbamazepine.
Topics: Aged; Beriberi; Carbamazepine; Humans; Male; Paresthesia; Peripheral Nervous System Diseases | 1988 |
Quantitative vibration perception thresholds in patients under prolonged antiepileptic treatment.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Drug Therapy, Combination; Female; H | 1985 |
[Physiopathology and treatment of flashing pains].
Topics: Carbamazepine; Dibenzazepines; Herpes Zoster; Humans; Neuralgia; Pain; Peripheral Nervous System Dis | 1971 |
Peripheral nerve function in long-term therapy with diphenylhydantoin. A clinical and electrophysiologic correlation.
Topics: Adult; Aged; Carbamazepine; Electric Stimulation; Electromyography; Epilepsy; Ethosuximide; Evoked P | 1974 |